These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9606809

  • 1. Dysregulation of apoptosis in hepatocellular carcinoma.
    Thorgeirsson SS, Teramoto T, Factor VM.
    Semin Liver Dis; 1998; 18(2):115-22. PubMed ID: 9606809
    [Abstract] [Full Text] [Related]

  • 2. Biology of transforming growth factor beta in hepatocarcinogenesis.
    Rossmanith W, Schulte-Hermann R.
    Microsc Res Tech; 2001 Feb 15; 52(4):430-6. PubMed ID: 11170302
    [Abstract] [Full Text] [Related]

  • 3. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
    Tanaka S, Wands JR.
    Cancer Res; 1996 Aug 01; 56(15):3391-4. PubMed ID: 8758899
    [Abstract] [Full Text] [Related]

  • 4. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A, Wang NJ, Xie JP, Thorgeirsson SS.
    Clin Cancer Res; 1997 Jul 01; 3(7):1059-66. PubMed ID: 9815784
    [Abstract] [Full Text] [Related]

  • 5. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I.
    Cancer Res; 2009 Oct 01; 69(19):7595-602. PubMed ID: 19773433
    [Abstract] [Full Text] [Related]

  • 6. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2000 Aug 01; 32(2):218-27. PubMed ID: 10915727
    [Abstract] [Full Text] [Related]

  • 7. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
    Lin SJ, Chang C, Ng AK, Wang SH, Li JJ, Hu CP.
    Apoptosis; 2007 Sep 01; 12(9):1659-70. PubMed ID: 17624592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Chen RH, Su YH, Chuang RL, Chang TY.
    Oncogene; 1998 Oct 15; 17(15):1959-68. PubMed ID: 9788439
    [Abstract] [Full Text] [Related]

  • 15. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ, Kim BC, Kim SJ, Choi KS.
    Hepatology; 2002 Jun 15; 35(6):1360-71. PubMed ID: 12029621
    [Abstract] [Full Text] [Related]

  • 16. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY, Park YN, Kim H, Park C.
    Mod Pathol; 2003 Jan 15; 16(1):86-96. PubMed ID: 12527718
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
    Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernández M, Fabregat I.
    J Hepatol; 2008 Dec 15; 49(6):965-76. PubMed ID: 18845355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.